JP2024524458A5 - - Google Patents
Info
- Publication number
- JP2024524458A5 JP2024524458A5 JP2023580901A JP2023580901A JP2024524458A5 JP 2024524458 A5 JP2024524458 A5 JP 2024524458A5 JP 2023580901 A JP2023580901 A JP 2023580901A JP 2023580901 A JP2023580901 A JP 2023580901A JP 2024524458 A5 JP2024524458 A5 JP 2024524458A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclo
- compound
- bicyclo
- aforementioned
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024175605A JP2025001006A (ja) | 2021-06-30 | 2024-10-07 | トランスグルタミナーゼの阻害剤 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21182956.9 | 2021-06-30 | ||
| EP21182956 | 2021-06-30 | ||
| EP21183316 | 2021-07-01 | ||
| EP21183316.5 | 2021-07-01 | ||
| US202163217783P | 2021-07-02 | 2021-07-02 | |
| US63/217,783 | 2021-07-02 | ||
| EPPCT/EP2021/086674 | 2021-12-17 | ||
| PCT/EP2021/086674 WO2023110138A1 (en) | 2021-12-17 | 2021-12-17 | Inhibitors of transglutaminases |
| EP2022065430 | 2022-06-07 | ||
| EPPCT/EP2022/065430 | 2022-06-07 | ||
| PCT/EP2022/068216 WO2023275336A1 (en) | 2021-06-30 | 2022-06-30 | Inhibitors of transglutaminases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024175605A Division JP2025001006A (ja) | 2021-06-30 | 2024-10-07 | トランスグルタミナーゼの阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024524458A JP2024524458A (ja) | 2024-07-05 |
| JP2024524458A5 true JP2024524458A5 (cg-RX-API-DMAC7.html) | 2024-08-20 |
| JP7696024B2 JP7696024B2 (ja) | 2025-06-19 |
Family
ID=82547318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580901A Active JP7696024B2 (ja) | 2021-06-30 | 2022-06-30 | トランスグルタミナーゼの阻害剤 |
| JP2024175605A Pending JP2025001006A (ja) | 2021-06-30 | 2024-10-07 | トランスグルタミナーゼの阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024175605A Pending JP2025001006A (ja) | 2021-06-30 | 2024-10-07 | トランスグルタミナーゼの阻害剤 |
Country Status (20)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL309476A (en) * | 2021-06-30 | 2024-02-01 | Zedira Gmbh | Transglutaminase inhibitors |
| PL4192813T3 (pl) * | 2021-06-30 | 2024-12-23 | Zedira Gmbh | Inhibitory transglutaminaz |
| DK4192812T3 (da) * | 2021-06-30 | 2024-09-16 | Zedira Gmbh | Transglutaminase-inhibitorer |
| JP7805983B2 (ja) | 2022-03-22 | 2026-01-26 | アッヴィ・インコーポレイテッド | ブルトン型チロシンキナーゼを分解するためのピリミジン |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006052755A1 (de) * | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | Michaelsysteme als Transglutaminaseinhibitoren |
| EP2687511A1 (de) | 2012-07-17 | 2014-01-22 | Zedira GmbH | Pyridinonderivate als Gewebetransglutaminaseinhibitoren |
| EP3342779A1 (en) * | 2016-12-27 | 2018-07-04 | Zedira GmbH | Inhibitors of transglutaminases |
| IL309476A (en) * | 2021-06-30 | 2024-02-01 | Zedira Gmbh | Transglutaminase inhibitors |
| PL4192813T3 (pl) * | 2021-06-30 | 2024-12-23 | Zedira Gmbh | Inhibitory transglutaminaz |
-
2022
- 2022-06-30 PL PL22741487.7T patent/PL4192813T3/pl unknown
- 2022-06-30 LT LTEPPCT/EP2022/068216T patent/LT4192813T/lt unknown
- 2022-06-30 JP JP2023580901A patent/JP7696024B2/ja active Active
- 2022-06-30 IL IL309474A patent/IL309474A/en unknown
- 2022-06-30 FI FIEP22741487.7T patent/FI4192813T3/fi active
- 2022-06-30 DK DK22741487.7T patent/DK4192813T3/da active
- 2022-06-30 RS RS20241217A patent/RS66138B1/sr unknown
- 2022-06-30 AU AU2022305117A patent/AU2022305117A1/en active Pending
- 2022-06-30 EP EP22741487.7A patent/EP4192813B1/en active Active
- 2022-06-30 CN CN202280045270.7A patent/CN117561241B/zh active Active
- 2022-06-30 US US18/572,114 patent/US20240376055A1/en active Pending
- 2022-06-30 ES ES22741487T patent/ES2991364T3/es active Active
- 2022-06-30 MX MX2023015490A patent/MX2023015490A/es unknown
- 2022-06-30 HR HRP20241524TT patent/HRP20241524T1/hr unknown
- 2022-06-30 KR KR1020247003631A patent/KR20240028473A/ko active Pending
- 2022-06-30 WO PCT/EP2022/068216 patent/WO2023275336A1/en not_active Ceased
- 2022-06-30 HU HUE22741487A patent/HUE068818T2/hu unknown
- 2022-06-30 SI SI202230064T patent/SI4192813T1/sl unknown
-
2023
- 2023-12-22 US US18/394,766 patent/US20240270715A1/en active Pending
- 2023-12-29 CL CL2023003979A patent/CL2023003979A1/es unknown
-
2024
- 2024-01-24 ZA ZA2024/00823A patent/ZA202400823B/en unknown
- 2024-10-07 JP JP2024175605A patent/JP2025001006A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7576095B2 (en) | Therapeutic agents | |
| JP2010540508A5 (cg-RX-API-DMAC7.html) | ||
| WO1998022432A1 (en) | Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same | |
| JP2018517731A5 (cg-RX-API-DMAC7.html) | ||
| CS208112B2 (en) | Method of making the new fluoralcylsubstituted derivatives of theacylanilides | |
| JP2024541920A5 (cg-RX-API-DMAC7.html) | ||
| JP2024528557A5 (cg-RX-API-DMAC7.html) | ||
| PL200028B1 (pl) | Pochodne monoazotanu izosorbidu i ich zastosowanie do wytwarzania leku o działaniu rozszerzającym naczynia krwionośne i zmniejszoną tolerancją oraz kompozycja farmaceutyczna | |
| JP2020500205A5 (cg-RX-API-DMAC7.html) | ||
| HRP20241524T1 (hr) | Inhibitori transglutaminaza | |
| JP2015504917A (ja) | Mogat−2阻害剤として有用な新規モルホリニル誘導体 | |
| JPH0610174B2 (ja) | アミノフエノ−ル誘導体 | |
| EP0548680A1 (en) | Beta-oxo-beta-benzenepropanethioamide derivatives | |
| CA2502505A1 (fr) | Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine | |
| JPH01132582A (ja) | テトラヒドロフランの2,4−二置換誘導体 | |
| JP5556078B2 (ja) | キラル化合物の製造方法および製造中間体 | |
| JPS58201765A (ja) | ジヒドロピリジン誘導体,その製造法および用途 | |
| JP2018016577A (ja) | エステル化合物の製造方法 | |
| Kawashima et al. | Structure-activity relationship study of TXA2 receptor antagonists. 4-[2-(4-substituted phenylsulfonylamino) ethylthio] phenoxyacetic acids and related compounds | |
| JPH0789898A (ja) | ビフェニル誘導体 | |
| FR2670780A1 (fr) | Derives de 4-(acylamino)benzopyranes, leur preparation et leur application en therapeutique. | |
| FI89599C (fi) | Foerfarande foer framstaellning av terapeutiskt verksam 9,10-dihydro-4h-benso/4,5/cyklohepta/1,2-b/selenofen-9-on och -10-on | |
| CN110724040A (zh) | 碘代三氟甲氧基化合物的合成方法 | |
| JP3778521B2 (ja) | シクロプロペノンアセタール誘導体の製造法 | |
| JPS6320228B2 (cg-RX-API-DMAC7.html) |